Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Federal Trade Commission
Argus Health

Generated: March 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040110

« Back to Dashboard

NDA 040110 describes MEPERIDINE HYDROCHLORIDE, which is a drug marketed by Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Barr, Duramed Pharms Barr, Epic Pharma, Mikart, Specgx Llc, Sun Pharm Inds Inc, Sun Pharm Industries, Vintage Pharms, Wyeth Ayerst, Hospira, and Icu Medical Inc, and is included in forty-two NDAs. It is available from eight suppliers. Additional details are available on the MEPERIDINE HYDROCHLORIDE profile page.

The generic ingredient in MEPERIDINE HYDROCHLORIDE is meperidine hydrochloride. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
Summary for 040110
Applicant:West-ward Pharms Int
Ingredient:meperidine hydrochloride
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Pharmacology for NDA: 040110
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 040110
Suppliers and Packaging for NDA: 040110
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040110 ANDA West-Ward Pharmaceuticals Corp. 0054-4595 N 0054-4595-25
MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040110 ANDA West-Ward Pharmaceuticals Corp. 0054-4596 N 0054-4596-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Mar 12, 1997TE:AARLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Mar 12, 1997TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.